Abstract
BACKGROUND: Research on the cost of care of patients with cystic fibrosis is scarce. The aim of this study was to estimate the costs using age-specific medical consumption from real patient data. METHODS: The age-specific medical consumption of patients with cystic fibrosis in The Netherlands in 1991 was estimated from a survey of medical records and a patient questionnaire. A distinction was made between costs of hospital care, hospital and non-hospital medication, and home care. Costs per year were obtained by multiplying the yearly amount of care and the costs per unit. RESULTS: On average the annual cost of a patient with cystic fibrosis in 1991 was 10,908 pounds (hospital care 42%, medication 37%, home care 20%). The cost of care of cystic fibrosis in The Netherlands, with approximately 1000 patients, is estimated at 10.9 million pounds per year, which is 0.07% of the total health care budget. The cost of care of a patient up to the age of 35 is estimated at 614,587 pounds. When year-to-year survival is taken into account and future costs are discounted to the year of birth with a yearly discount rate of 5%, the cost of care of a patient with cystic fibrosis is estimated at 164,365 pounds for 1991. This estimate will be used in a prospective evaluation of screening for cystic fibrosis carriers. CONCLUSIONS: The cost of care of patients with cystic fibrosis estimated by age-specific medical consumption of real patients is higher than that estimated by non-age-specific medical consumption and/or expert opinions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bakker W., Vinks A. A., Mouton J. W., de Jonge P., Verzijl J. G., Heijerman H. G. Continue intraveneuze thuisbehandeling van luchtweginfecties met ceftazidim via een draagbare pomp bij patiënten met cystische fibrose; een multicentrisch onderzoek. Ned Tijdschr Geneeskd. 1993 Nov 27;137(48):2486–2491. [PubMed] [Google Scholar]
- Donati M. A., Guenette G., Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr. 1987 Jul;111(1):28–33. doi: 10.1016/s0022-3476(87)80337-2. [DOI] [PubMed] [Google Scholar]
- Ginsberg G., Blau H., Kerem E., Springer C., Kerem B. S., Akstein E., Greenberg A., Kolumbos A., Abeliovich D., Gazit E. Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population. Health Econ. 1994 Jan-Feb;3(1):5–23. doi: 10.1002/hec.4730030104. [DOI] [PubMed] [Google Scholar]
- Robson M., Abbott J., Webb K., Dodd M., Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992 Sep;47(9):684–689. doi: 10.1136/thx.47.9.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strandvik B., Hjelte L., Malmborg A. S., Widén B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr. 1992 Apr;81(4):340–344. doi: 10.1111/j.1651-2227.1992.tb12239.x. [DOI] [PubMed] [Google Scholar]
- van Ineveld B. M., van Oortmarssen G. J., de Koning H. J., Boer R., van der Maas P. J. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer. 1993;29A(12):1663–1668. doi: 10.1016/0959-8049(93)90100-t. [DOI] [PubMed] [Google Scholar]